Evidence map›Paper›PMID 33508124›Full record

Observational studyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2022

Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.

José Luis Gorriz, Luis D'Marco, Anna Pastor-González, Pablo Molina, Miguel Gonzalez-Rico, María Jesús Puchades, Irina Sanchis, Verónica Escudero, Nuria Estañ, Rafael de la Espriella and 3 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Management of hyperkalemia: Expert consensus from Kuwait - a Modified Delphi Approach.International journal of nephrology and renovascular disease · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

José Luis GorrizDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.ORCID 0000-0002-1134-9051
Luis D'MarcoDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Anna Pastor-GonzálezDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Pablo MolinaDepartment of Nephrology, Hospital Universitario Dr Peset, Universitat de València, Valencia, Spain.ORCID 0000-0002-8311-6214
Miguel Gonzalez-RicoDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
María Jesús PuchadesDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Irina SanchisDepartment of Nephrology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Verónica EscuderoDepartment of Nephrology, Hospital Universitario Dr Peset, Universitat de València, Valencia, Spain.
Nuria EstañClinical Analysis Service, Dr Peset University Hospital, Valencia, Spain.
Rafael de la EspriellaDepartment of Cardiology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Eduardo NuñezDepartment of Cardiology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Luis PallardóDepartment of Nephrology, Hospital Universitario Dr Peset, Universitat de València, Valencia, Spain.
Julio NúñezDepartment of Cardiology, Clínico University Hospital, INCLIVA, Universitat de València, Valencia, Spain.
Universitat de València · ESHospital Universitario Doctor Peset · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that is associated with a higher risk of adverse clinical events such as ventricular arrhythmias and sudden cardiac death. Currently, data regarding the prognostic implications of chronic hyperkalaemia are available; however, information about the long-term clinical consequences after an episode of severe hyperkalaemia remains scarce. The objective of this study was to evaluate the association between the trajectory of potassium measurements in patients with acute hyperkalaemia and long-term all-cause mortality.

methodsThis is a retrospective observational study that included patients with acute severe hyperkalaemia [potassium (K) >6 mEq/L] without haemolysis in the emergency room of Dr Peset University Hospital in Valencia, Spain searching the lab database from January 2016 to March 2017. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modelling.

resultsWe found 172 episodes of acute hyperkalaemia in 160 patients in the emergency room. The mean ± standard deviation age of the sample was 77 ± 12 years and 60.5% were males. The most frequent comorbidities were CKD (71.2%), HF (35%) and diabetes mellitus (56.9%). Only 11.9% of the patients were on chronic dialysis. A quarter of the patients did not have previous CKD, making hyperkalaemia an unpredictable life-threatening complication. During the acute episode, mean potassium and estimated glomerular filtration rate (eGFR) were 6.6 ± 0.6 (range 6.1-9.2) mEq/L and 23 ± 16 (range 2-84) mL/min/1.73 m2, respectively. After a median (interquartile range) follow-up of 17.3 (2.2-23.7) months, 68 patients died (42.5%). Recurrences of hyperkalaemia (K >5.5 mEq/L) were detected in 39.5% of the patients who were monitored during follow-up. We found that previous potassium levels during an acute severe hyperkalaemia episode were not predictors of mortality. Conversely, the post-discharge longitudinal trajectories of potassium were able to predict all-cause mortality (overall P = 0.0015). The effect of transitioning from hyperkalaemia to normokalaemia (K >5.5 mEq/L to K ≤5.5 mEq/L) after the acute episode was significant, and inversely associated with the risk of mortality.

conclusionsPotassium levels prior to a severe hyperkalaemic event do not predict mortality. Conversely, following an episode of acute severe hyperkalaemia, serial kinetics of potassium trajectories predict the risk of death. Further evidence is needed to confirm these findings and clarify the optimal long-term management of these patients.

Indexed as

HyperkalemiaRenal Insufficiency, ChronicAftercareAgedAged, 80 and overHumansMalePatient DischargePotassiumPotassiumhyperkalaemialongitudinal studiesmortalitypost-dischargepotassium

Identifiers

PMID33508124
PMCPMC8875445
OpenAlexW3122298974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.